| Entity | 2025 Donation | % of Gross Revenue |
| Abbvie Inc. | $10,000.00 | 0.02% |
| Amgen, Inc. | $400,000.00 | 0.80% |
| Astellas Pharma US, Inc. | $30,000.00 | 0.06% |
| Astrazeneca Pharmaceuticals LP | $197,400.00 | 0.39% |
| Bayer Corporation | $38,322.00 | 0.08% |
| BeiGene USA Inc. | $85,000.00 | 0.17% |
| Biotechnology Innovation Organization | $25,000.00 | 0.05% |
| Blueprint Medicines Corp | $109,175.00 | 0.22% |
| Bristol-Myers Squibb | $627,175.00 | 1.25% |
| CellCentric | $20,000.00 | 0.04% |
| Cogent Biosciences | $5,000.00 | 0.01% |
| Daiichi Sankyo Inc. | $5,000.00 | 0.01% |
| Eisai Corporation of North America | $25,000.00 | 0.05% |
| EMD Serono Inc. | $100,000.00 | 0.20% |
| Exelixis Inc. | $50,000.00 | 0.10% |
| Genentech Inc. | $1,500,000.00 | 3.00% |
| Genmab | $120,000.00 | 0.24% |
| Gilead Sciences Inc. | $57,500.00 | 0.12% |
| GlaxoSmithKline | $82,000.00 | 0.16% |
| IPSEN Pharmaceuticals | $65,000.00 | 0.13% |
| Johnson & Johnson | $472,360.00 | 0.94% |
| Kura Oncology | $5,000.00 | 0.01% |
| Lilly | $285,000.00 | 0.57% |
| Massachusetts Biotechnology Council | $10,000.00 | 0.02% |
| Merck & Co Inc. | $469,000.00 | 0.94% |
| Moderna Inc. | $50,000.00 | 0.10% |
| Novartis Pharmaceuticals Corporation | $335,000.00 | 0.67% |
| Novocure | $85,000.00 | 0.17% |
| Organon | $50,000.00 | 0.10% |
| Pfizer Inc. | $608,525.00 | 1.22% |
| Pharmaceutical Research And Manufacturers of America (PhRMA) | $477,110.00 | 0.95% |
| Regeneron Pharmaceuticals | $105,000.00 | 0.21% |
| Relay Therapeutics | $5,000.00 | 0.01% |
| Revolution Medicines | $10,000.00 | 0.02% |
| RI Life Science Hub | $2,500.00 | 0.01% |
| Sandoz | $5,000.00 | 0.01% |
| Sanofi US LLC | $82,200.00 | 0.16% |
| Servier Pharmaceuticals LLC | $15,000.00 | 0.03% |
| Takeda Oncology | $20,000.00 | 0.04% |
